The Role of the Family and Improvement in Treatment Maintenance, Adherence, and Outcome for Schizophrenia
Authors:
- Ira D. GlickIGIra D. Glick
- Anya H. StekollASAnya H. Stekoll
- Spencer HaysSHSpencer Hays
- 1 February 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 31 (1) , 82-85
Abstract
In the context of a large, random assignment, controlled study evaluating the relative effectiveness and safety of antipsychotic medication (CATIE), we examined the relationship between treatment outcome and 2 family variables: their presence and their ability to support treatment adherence. Post hoc, we assessed the 50 study patients (40 of whom had families) and their families by dividing them into 2 groups. The first had a family/significant other, available and mostly supportive, to work collaboratively on adherence with the treatment team (n = 27). The second group either did not have the family/significant other or, if they did, lacked support for long-term maintenance (n = 23). Next, we examined outcome on 2 measures: study completion (vs discontinuation) and global outcome. Of 27 patients with available/supportive families, 23 remained in treatment for the full study course. In contrast, 13 of 23 patients, who were discontinued or dropped out, either did not have families or, if they had them, were unable to support adherence (P < 0.01). As to global outcome, 24 of the 27 patients who had supportive families improved, compared with only 9 of the 23 of the other group (P < 0.001). In summary, in the context of a large medication efficacy-effectiveness trial, we present data suggesting that having a "family" available and supportive (regardless of the interpersonal issues between patient and family) improves outcome mediated by improving long-term adherence.Keywords
This publication has 9 references indexed in Scilit:
- Use of a Critical Time Intervention to Promote Continuity of Care After Psychiatric Inpatient HospitalizationPsychiatric Services, 2009
- Questioning an Axiom: Better Prognosis for Schizophrenia in the Developing World?Schizophrenia Bulletin, 2007
- Measurement-Based Psychiatry: Definitions of Response, Remission, Stability, and Relapse in SchizophreniaThe Journal of Clinical Psychiatry, 2006
- Family support predicts psychiatric medication usage among Mexican American individuals with schizophreniaSocial Psychiatry and Psychiatric Epidemiology, 2006
- Family Psychoeducation as an Evidence-Based PracticeCNS Spectrums, 2004
- Discovering the Neural Basis of Human Social Anxiety: A Diagnostic and Therapeutic ImperativeAmerican Journal of Psychiatry, 2004
- The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project: Schizophrenia Trial Design and Protocol DevelopmentSchizophrenia Bulletin, 2003
- Evidence-Based Practices for Services to Families of People With Psychiatric DisabilitiesPsychiatric Services, 2001
- Implementing Evidence-Based Practices in Routine Mental Health Service SettingsPsychiatric Services, 2001